BRAF-MEK Inhibition Achieves ‘Near Universal’ Response in Rare Brain Tumor
Targeted BRAF-MEK inhibition resulted in a response in nearly all patients with untreated BRAF V600E–mutated papillary craniopharyngioma, according to results ...
Read moreDetails
